The University of Graz, together with the Styrian start-up business Innophore, is researching how to decrypt the structure of SARS-CoV-2. Their aim is to find an active ingredient fighting the virus. In this video Karl Gruber, Institute of Molecular Bioscienes, describes the current status and explains why already approved drugs are the key to success.